Wugen Competitors and Similar CompaniesClear all
Wugen's competitors and similar companies include Immatics, Pharming Group, PlasmaGen Biosciences and Abiogen Pharma.
 Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. |  PlasmaGen Biosciences PlasmaGen BioSciences is a bio-pharmaceutical organization specializing in plasma protein therapy. |  Abiogen Pharma Abiogen Pharma is a specialist pharmaceutical company that focuses on bone metabolism and rare diseases. | ||
Founding Date | Founding Date 2018 | Founding Date N/A | Founding Date 1988 | Founding Date 2010 | Founding Date 1997 |
Type | Type Private | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations St. Louis, US HQ San Diego, US | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Leiden, NL HQ Leiden, NL | Locations Bengaluru, IN HQ Bengaluru, IN | Locations Pisa, IT HQ |
Employees | Employees 662% increase | Employees 29723% increase | Employees 404 | Employees 4032% increase | Employees 351 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) 590.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $41.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €53m (FY, 2025) | Gross profit $341m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income (€196.4m) (FY, 2025) | Net income $2.5m (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 267.3m | Total funding raised N/A | Total funding raised $ 25m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View companyPharming Group
HQ
Leiden, NL
Employees
404
Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
View companyPlasmaGen Biosciences
HQ
Bengaluru, IN
Employees
403↑ 2% increase
PlasmaGen BioSciences is a bio-pharmaceutical organization specializing in plasma protein therapy.
View companyAbiogen Pharma
HQ
Pisa, IT
Abiogen Pharma is a specialist pharmaceutical company that focuses on bone metabolism and rare diseases.
View company